Finally, normal D and cancer 3 retained common markers of CAPs, including RGS5, MCAM, and CRIP1, pathways relating to contractility and cytoskeletal rearrangements, and activity of transcription factors associated with muscle contractility, including MYOG. This evidence concerns the gene RGS5 and cancer.